# Acute and Chronic Diarrhea - Systematic Approach

## Definitions

Diarrhea is defined as 3 or more loose or watery stools per day, or a stool weight exceeding 200 g per day. The temporal classification distinguishes acute diarrhea (less than 14 days in duration), persistent diarrhea (14 to 30 days), and chronic diarrhea (more than 30 days, though some authorities use a threshold of 4 weeks).

## Acute Diarrhea

### Etiologic Categories

#### Infectious (90% of acute diarrhea)

Infectious agents account for approximately 90% of acute diarrhea cases. Viral pathogens are the most common, with norovirus being the leading cause overall, followed by rotavirus (primarily in children), adenovirus, and astrovirus. Viral gastroenteritis is typically self-limited, resolving within 1 to 3 days.

Bacterial diarrhea is divided into non-inflammatory (watery) and inflammatory (bloody or dysenteric) patterns. Non-inflammatory bacterial diarrhea is caused by enterotoxigenic E. coli (ETEC, the most common cause of traveler's diarrhea), Vibrio cholerae, Staphylococcus aureus toxin, Bacillus cereus toxin, and Clostridium perfringens. Inflammatory bacterial diarrhea is caused by Shigella, Salmonella, Campylobacter, enterohemorrhagic E. coli (EHEC/O157:H7), Clostridioides difficile, Yersinia, and enteroinvasive E. coli.

Parasitic causes include Giardia lamblia, Cryptosporidium, Entamoeba histolytica, and Cyclospora cayetanensis. Foodborne illness typically has its onset within 6 to 24 hours of ingestion. Preformed toxins from S. aureus and B. cereus cause symptoms within 1 to 6 hours, C. perfringens within 8 to 16 hours, and Salmonella and Campylobacter within 12 to 72 hours.

#### Non-Infectious

Non-infectious causes of acute diarrhea include medication-related etiologies (antibiotics, NSAIDs, metformin, colchicine, SSRIs, and magnesium-containing antacids), dietary indiscretion (excessive fructose, sorbitol, caffeine, or alcohol), ischemic colitis, and the initial presentation of chronic diseases such as IBD or celiac disease.

### Clinical Evaluation of Acute Diarrhea

Most cases of acute diarrhea are self-limited and do not require diagnostic testing. Indications for stool testing include bloody diarrhea, severe dehydration, duration exceeding 7 days, immunocompromised status, recent hospitalization or antibiotic use (raising suspicion for C. difficile), recent travel, and community outbreak settings. Available stool studies include culture for Salmonella, Shigella, and Campylobacter, C. difficile testing, ova and parasites examination (if travel history or immunosuppression is present), and multiplex PCR panels (such as BioFire), which detect 22 targets with high sensitivity but may detect carriage rather than active infection.

### Treatment of Acute Diarrhea

Oral rehydration is the cornerstone of management, using the WHO oral rehydration solution or sports drinks for mild cases and intravenous fluids for severe dehydration. Antimotility agents such as loperamide (4 mg initially, then 2 mg after each loose stool, maximum 16 mg per day) provide symptomatic relief but must be avoided in bloody diarrhea, suspected EHEC (risk of hemolytic uremic syndrome), and C. difficile infection.

Empiric antibiotics are indicated for moderate-to-severe traveler's diarrhea, dysentery (bloody diarrhea with fever), and immunocompromised patients. Azithromycin at 1,000 mg as a single dose or 500 mg daily for 3 days is preferred, particularly for Campylobacter and typhoid fever. Fluoroquinolones (ciprofloxacin 500 mg twice daily for 3 to 5 days) are an alternative but face increasing resistance and should be avoided empirically in Southeast Asia. Rifaximin at 200 mg three times daily for 3 days is appropriate only for non-invasive traveler's diarrhea. Critically, antibiotics must be avoided in suspected EHEC (O157:H7) infection, as they may increase the risk of hemolytic uremic syndrome; supportive care alone is indicated.

<image>A clinical decision algorithm for acute diarrhea management. Start with "Acute diarrhea (<14 days)." First assessment: "Severity evaluation" — branches to "Mild (no dehydration, no systemic signs)" leading to "Supportive care: oral rehydration, dietary modification, consider loperamide"; and "Moderate-Severe (dehydration, bloody stools, fever >38.5°C, >6 stools/day, immunocompromised)" leading to "Stool studies + empiric therapy consideration." Under stool studies, show a panel: "Stool culture, C. difficile testing, O&P (if travel/immunosuppression), multiplex PCR." Decision branch: "Bloody diarrhea?" If yes: "Avoid loperamide; obtain stool culture; avoid antibiotics if EHEC suspected (thrombocytopenia, renal failure); treat with azithromycin if Shigella/Campylobacter suspected." If no bloody diarrhea: "Consider empiric azithromycin for traveler's diarrhea; rifaximin for non-invasive disease." Include a "Red flags requiring hospitalization" box: severe dehydration, hemodynamic instability, inability to tolerate oral intake, bloody diarrhea with systemic toxicity, elderly with comorbidities. Use red for high-risk pathways, green for low-risk/supportive care.</image>

## Chronic Diarrhea — Pathophysiologic Classification

### Watery Diarrhea

| Category | Osmotic Gap | Fasting Response | Key Causes | Diagnostic Tests |
|---|---|---|---|---|
| Osmotic | >75 mOsm/kg | Improves/resolves | Lactose/fructose malabsorption, Mg laxatives, celiac, pancreatic insufficiency | Hydrogen breath test, dietary review, fecal elastase |
| Secretory | <50 mOsm/kg | Persists | Microscopic colitis, bile acid malabsorption, neuroendocrine tumors, medications | Colonoscopy with random biopsies, C4/SeHCAT, chromogranin A, 5-HIAA |
| Inflammatory | N/A (blood, WBC in stool) | Persists | IBD, infection (C. diff, CMV), ischemic colitis, malignancy | Fecal calprotectin, ileocolonoscopy with biopsies, stool studies |
| Fatty (steatorrhea) | N/A (fecal fat >7 g/day) | Variable | Pancreatic insufficiency, celiac, Whipple, bile acid deficiency, short bowel | Fecal elastase, 72h fecal fat, small bowel biopsies, secretin MRCP |

#### Osmotic Diarrhea

Osmotic diarrhea results from non-absorbed, osmotically active solutes in the intestinal lumen. The stool osmotic gap, calculated as 290 minus twice the sum of stool sodium and stool potassium, is the key diagnostic tool: a value greater than 75 mOsm/kg indicates osmotic diarrhea, while a value less than 50 indicates secretory diarrhea. Osmotic diarrhea characteristically improves or resolves with fasting. Common causes include lactose and fructose malabsorption, sorbitol and mannitol ingestion, magnesium-containing laxatives and antacids, celiac disease, pancreatic insufficiency, and short bowel syndrome. A very low stool osmotic gap (below 50) in the setting of high measured stool osmolarity should raise suspicion for factitious diarrhea from the addition of water to the specimen.

#### Secretory Diarrhea

Secretory diarrhea results from active ion secretion or impaired absorption and is characterized by large-volume diarrhea that persists with fasting. The stool osmotic gap is less than 50 mOsm/kg. Causes include microscopic colitis, bile acid malabsorption, neuroendocrine tumors (VIPoma, carcinoid syndrome, gastrinoma, and medullary thyroid carcinoma), Addison disease, medications (colchicine, metformin, SSRIs), congenital chloride diarrhea, and Brainerd diarrhea.

#### Functional Diarrhea

Functional diarrhea, defined by Rome IV criteria, presents as painless chronic watery diarrhea without an identified organic cause and is distinct from IBS.

### Inflammatory Diarrhea

Inflammatory diarrhea is characterized by the presence of blood, mucus, and leukocytes in the stool, with elevated fecal calprotectin and lactoferrin. Causes include inflammatory bowel disease (Crohn disease and ulcerative colitis), infections (C. difficile, CMV, tuberculosis), ischemic colitis, radiation colitis, malignancy (colorectal cancer and lymphoma), and diverticulitis with associated colitis.

### Fatty Diarrhea (Steatorrhea)

Fatty diarrhea is defined by excess fecal fat exceeding 7 g per day on a 100 g fat diet. It may result from maldigestion due to pancreatic exocrine insufficiency or bile acid deficiency, or from malabsorption due to celiac disease, tropical sprue, Whipple disease, small bowel Crohn disease, short bowel syndrome, amyloidosis, or intestinal lymphangiectasia.

## Diagnostic Approach to Chronic Diarrhea

### Step 1: History and Examination

A thorough history should address duration, frequency, timing (nocturnal diarrhea strongly suggests an organic etiology), relationship to meals and fasting, and stool characteristics (watery, bloody, greasy or floating, or mucoid). Dietary history should specifically inquire about lactose, fructose, artificial sweeteners, gluten, caffeine, alcohol, and supplement use. A comprehensive medication review including supplements, laxatives, and herbal products is essential and frequently overlooked. Surgical history is important, particularly cholecystectomy (which predisposes to bile acid diarrhea), bariatric surgery, and small bowel or ileal resection. Travel history, exposures, sexual history (for STI-associated proctitis), immunosuppression status, and family history of IBD, celiac disease, colorectal cancer, or endocrine tumors should all be explored. Systemic symptoms including weight loss (suggesting organic disease), fever, joint pain, and skin rash provide additional diagnostic clues.

### Step 2: Initial Laboratory Testing

Initial testing should include a CBC with differential (looking for anemia, eosinophilia, and lymphopenia), comprehensive metabolic panel (electrolytes, renal function, albumin, and calcium), CRP and ESR (for inflammatory markers), TSH (to exclude hyperthyroidism), celiac serologies (tTG-IgA and total serum IgA), fecal calprotectin (to distinguish IBD from functional disease), and stool studies including C. difficile testing, stool culture, ova and parasites (if exposure risk exists), and Giardia antigen.

### Step 3: Categorize by Stool Characteristics

Further characterization involves measuring stool osmolality and electrolytes (sodium and potassium) to calculate the osmotic gap, performing fecal fat analysis (qualitative Sudan stain or quantitative 72-hour collection), measuring fecal elastase-1 (for pancreatic insufficiency), and measuring fecal calprotectin or lactoferrin (for inflammation).

### Step 4: Targeted Testing Based on Category

For osmotic diarrhea, hydrogen breath testing (lactose and fructose), dietary review, and celiac biopsies are indicated. For secretory diarrhea, colonoscopy with random biopsies (for microscopic colitis), serum bile acid testing (C4 or empiric sequestrant trial), and if suspicion is high, a neuroendocrine workup (chromogranin A, 5-HIAA, VIP, gastrin, calcitonin) with CT or MRI for structural lesions should be pursued. For inflammatory diarrhea, ileocolonoscopy with biopsies, CT or MR enterography, and an infectious workup are appropriate. For fatty diarrhea, fecal elastase, upper endoscopy with small bowel biopsies, CT or MR enterography, and secretin-stimulated MRCP guide the evaluation.

## Important Specific Diagnoses

### Microscopic Colitis

Microscopic colitis encompasses two subtypes: collagenous colitis, characterized by a thickened subepithelial collagen band exceeding 10 micrometers, and lymphocytic colitis, characterized by more than 20 intraepithelial lymphocytes per 100 surface epithelial cells. It presents as chronic watery, non-bloody diarrhea and predominantly affects women over 50 years of age. The colonoscopy appears entirely normal, and diagnosis requires random biopsies from both the right and left colon, with a minimum of 2 biopsies per segment. Associated conditions include autoimmune diseases (celiac disease in 5 to 10% and thyroid disease) and medication use (NSAIDs, PPIs, SSRIs, checkpoint inhibitors, and ranitidine). Treatment begins with budesonide 9 mg daily for induction, achieving remission in 80 to 90% of patients, followed by a taper to 3 mg for maintenance. Alternative therapies include cholestyramine, bismuth subsalicylate, and immunomodulators or biologics for refractory cases, with vedolizumab having the most supporting evidence.

### Neuroendocrine Tumor-Related Diarrhea

Carcinoid syndrome results from serotonin-producing neuroendocrine tumors, usually midgut tumors with liver metastases. The clinical syndrome includes diarrhea, flushing, wheezing, and right-sided valvular heart disease. Diagnosis is established by elevated 24-hour urine 5-HIAA or serum 5-HIAA, and treatment consists of somatostatin analogs such as octreotide LAR at 20 to 30 mg intramuscularly every 4 weeks. VIPoma presents with the WDHA syndrome (watery diarrhea, hypokalemia, and achlorhydria), also known as Verner-Morrison syndrome, with diarrhea volumes often exceeding 3 liters per day. Serum VIP exceeding 75 pg/mL is diagnostic, and 90% of tumors are pancreatic in origin. Treatment involves octreotide and surgical resection. Medullary thyroid carcinoma produces calcitonin-mediated secretory diarrhea.

### Medication-Induced Diarrhea

Medication-induced diarrhea is extremely common and frequently overlooked. Common culprits include metformin (affecting 20 to 30% of users), colchicine, SSRIs, PPIs, magnesium supplements, NSAIDs, antibiotics, immune checkpoint inhibitors, mycophenolate, chemotherapy agents, and rarely ACE inhibitors. A comprehensive medication review should always precede an extensive diagnostic workup.

<image>A diagnostic categorization chart for chronic diarrhea organized by stool characteristics. Create a central hub labeled "Chronic Diarrhea (>4 weeks)" with four radiating branches: (1) "Watery — Osmotic" (osmotic gap >75): causes listed as lactose/fructose malabsorption, magnesium ingestion, celiac, pancreatic insufficiency; key test: improves with fasting, hydrogen breath test. (2) "Watery — Secretory" (osmotic gap <50): causes listed as microscopic colitis, bile acid malabsorption, neuroendocrine tumors, medications, Addison disease; key test: persists with fasting, colonoscopy with random biopsies, neuroendocrine markers. (3) "Inflammatory" (blood, elevated calprotectin): causes listed as IBD, infection, ischemia, malignancy, radiation; key test: ileocolonoscopy, CT/MR enterography. (4) "Fatty/Steatorrhea" (fecal fat >7 g/day): causes listed as pancreatic insufficiency, bile acid deficiency, celiac, Whipple, short bowel; key test: fecal elastase, small bowel biopsies. Use distinct colors for each branch (blue for osmotic, purple for secretory, red for inflammatory, yellow for fatty). Include the stool osmotic gap formula prominently: 290 - 2(Na + K). Add key diagnostic tests and expected lab values in boxes along each branch.</image>

## Chronic Diarrhea in Immunocompromised Patients

### HIV/AIDS

In patients with a CD4 count below 200, opportunistic pathogens including Cryptosporidium, Microsporidium, Isospora belli, CMV colitis, and Mycobacterium avium complex must be considered. In patients with CD4 above 200, standard pathogens and medication-related diarrhea (from antiretrovirals) are more common. The workup includes stool for modified acid-fast stain (detecting Cryptosporidium, Isospora, and Cyclospora), microsporida stain, flexible sigmoidoscopy with biopsies and CMV PCR or immunohistochemistry for CMV colitis, and MAC blood cultures.

### Solid Organ Transplant

Diarrhea in solid organ transplant recipients commonly results from mycophenolate (dose-dependent), CMV colitis (diagnosed with CMV PCR and colonoscopy with biopsies), C. difficile infection, and post-transplant lymphoproliferative disorder.

### Immune Checkpoint Inhibitor Colitis

Checkpoint inhibitor colitis is more common with ipilimumab (anti-CTLA-4) than with pembrolizumab or nivolumab (anti-PD-1/PD-L1). Grade 1 disease is managed with loperamide and monitoring. Grade 2 requires oral steroids (budesonide or prednisone at 1 mg/kg). Grade 3 to 4 disease requires intravenous methylprednisolone, with infliximab for steroid-refractory cases and vedolizumab if infliximab fails; the checkpoint inhibitor should be held. Colonoscopy with biopsies confirms the diagnosis, and the histologic pattern resembles IBD with active colitis and crypt damage.

## Key Clinical Pearls
- Stool osmotic gap is the most important initial classification tool for chronic watery diarrhea: >75 = osmotic, <50 = secretory
- Microscopic colitis requires random colonic biopsies from right AND left colon — the colonoscopy appears NORMAL
- Always calculate osmotic gap: fecal osmolality should approximate 290 mOsm/kg; measured osmolality >350 suggests specimen contamination or laxative abuse
- Bile acid malabsorption is underdiagnosed as a cause of chronic diarrhea (25-50% of IBS-D) — empiric cholestyramine trial is a reasonable diagnostic approach
- Medication-induced diarrhea is the most commonly overlooked etiology — comprehensive medication review should precede invasive testing
- EHEC (O157:H7): do NOT give antibiotics — increases HUS risk; supportive care only
- Fecal calprotectin <50 mcg/g has >95% NPV for IBD — extremely useful for triaging chronic diarrhea workup
- Carcinoid syndrome requires liver metastases to produce systemic symptoms (serotonin is cleared by first-pass hepatic metabolism)

## References
1. Riddle MS, et al. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. *Am J Gastroenterol*. 2016;111(5):602-622.
2. Schiller LR, et al. Chronic diarrhea: diagnosis and management. *Clin Gastroenterol Hepatol*. 2017;15(2):182-193.
3. Pardi DS. Diagnosis and Management of Microscopic Colitis. *Am J Gastroenterol*. 2017;112(1):78-85.
4. Shane AL, et al. IDSA Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. *Clin Infect Dis*. 2017;65(12):e45-e80.
5. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. *Gastroenterology*. 1999;116(6):1464-1486.